NL-OMON50122尚未招募不适用
99mTechnetium based PSMA-Radioguided Assisted surgery for prostate Cancer feasibility Study - TRACE
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Male, aged * 18 years.
- •* Hormone-sensitive recurrent protstate cancer after radical prostatectomy ,
- •external beam radiotherapy or brachytherapy
- •* Less than a number of 4 soft tissue lesions (lymph node; connective tissue)
- •within the pelvis or retroperitoneum with sufficient PSMA expression (*3 times
- •regional vascular activity level) as determined by PSMA-based PET
- •* PSA-value <4ng/mL
- •* Had a PSMA PET/CT within 60 days before surgery
- •* Suitable for salvage lymph node dissection, as per institutional guidelines.
- •* WHO performance status 0,1, or 2.
- •* Written informed consent.
排除标准
- •* Suspicion of local recurrent prostate cancer within the prostatic fossa not
- •treatable by surgery
- •* Nonregional lymphadenopathy (cM1a) or distant metastases (cM1b/c) as assessed
- •by preoperative PSMA PET/CT.
- •* Ongoing androgen deprivation therapy (ADT) or within 6 months prior to
- •* Severe claustrophobia interfering with PET/CT or SPECT/CT scanning
研究者
相似试验
Unknown
不适用
Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) StudyProstate CancerNCT03857113The Netherlands Cancer Institute20
招募中
1 期
To determine whether use of Technetium99m-labelled PSMA improves the sensitivity for detection and aids intra-operative localisation of lymph node metastases in men with intermediate or high-risk localised prostate cancer undergoing robotic-assisted radical prostatectomy.Prostate Cancer with lymph node metastasesCancer - ProstateACTRN12621001728820St. Vincent's Prostate Cancer Research Centre20
进行中（未招募）
2 期
MR-Guided Adaptive Stereotactic Body Radiotherapy (SBRT) of Primary Tumor for Pain Control in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) – a Randomized, Controlled Clinical StudyC25Malignant neoplasm of pancreasDRKS00025801MU Klinikum10
招募中
1 期
[177Lu]Lu-PSMAI&T radioligand therapy (PSMA-RLT) in patients with prostate cancer and biochemical but not radiomorphologic local recurrence after primary therapy with curative intention: a future planned phase II studyProstate cancerEUCTR2022-003713-11-ATMedical University of Vienna20
招募中
不适用
onradioactive surgical guidance with radiofrequency identification technology for locating nonpalpable breast lesionsBreast cancerNL-OMON22145Hologic200